| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
| Serial Number: 86126490 |
| Filing Date: 11/22/2013 |
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
86126490 |
| MARK INFORMATION |
| *MARK |
\\TICRS\EXPORT16\IMAGEOUT 16\861\264\86126490\xml1\ APP0002.JPG |
| SPECIAL FORM |
YES |
| USPTO-GENERATED IMAGE |
NO |
| LITERAL ELEMENT |
XELJANZ |
| COLOR MARK |
NO |
*DESCRIPTION OF THE MARK
(and Color Location, if applicable) |
The mark consists of word XELJANZ with starburst design. |
| PIXEL COUNT ACCEPTABLE |
YES |
| PIXEL COUNT |
876 x 253 |
| REGISTER |
Principal |
| APPLICANT INFORMATION |
| *OWNER OF MARK |
Pfizer Inc. |
| *STREET |
235 East 42nd Street |
| *CITY |
New York |
*STATE
(Required for U.S. applicants) |
New York |
| *COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
10017 |
| PHONE |
212-733-1112 |
| FAX |
212-573-2273 |
| LEGAL ENTITY INFORMATION |
| TYPE |
corporation |
| STATE/COUNTRY OF INCORPORATION |
Delaware |
| GOODS AND/OR SERVICES AND BASIS INFORMATION |
| INTERNATIONAL CLASS |
044 |
| *IDENTIFICATION |
health information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the
treatment of pain; on-line information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain |
| FILING BASIS |
SECTION 1(a) |
| FIRST USE ANYWHERE DATE |
At least as early as 11/30/2012 |
| FIRST USE IN COMMERCE DATE |
At least as early as 11/30/2012 |
| SPECIMEN FILE NAME(S) |
| ORIGINAL PDF FILE |
SPE0-16822416014-114151042_._RA_Treatment___XELJANZ___tofacitinib_citrate_.pdf |
CONVERTED PDF FILE(S)
(4 pages) |
\\TICRS\EXPORT16\IMAGEOUT16\861\264\86126490\xml1\APP0003.JPG |
| |
\\TICRS\EXPORT16\IMAGEOUT16\861\264\86126490\xml1\APP0004.JPG |
| |
\\TICRS\EXPORT16\IMAGEOUT16\861\264\86126490\xml1\APP0005.JPG |
| |
\\TICRS\EXPORT16\IMAGEOUT16\861\264\86126490\xml1\APP0006.JPG |
| SPECIMEN DESCRIPTION |
page from the xeljanz.com website |
| ADDITIONAL STATEMENTS SECTION |
| PRIOR REGISTRATION(S) |
The applicant claims ownership of U.S. Registration Number(s) 4099367. |
| ATTORNEY INFORMATION |
| NAME |
Seana Smith |
| ATTORNEY DOCKET NUMBER |
XELJANZ Logo/US |
| FIRM NAME |
Pfizer Inc. |
| STREET |
235 East 42nd Street |
| CITY |
New York |
| STATE |
New York |
| COUNTRY |
United States |
| ZIP/POSTAL CODE |
10017 |
| PHONE |
212-733-1112 |
| OTHER APPOINTED ATTORNEY |
Tiffany Trunko, Richard A. Friedman, Heather A. McDonald, Katrina Edge, Matthew A. Pater, Michele A. Farber |
| CORRESPONDENCE INFORMATION |
| NAME |
Seana Smith |
| FIRM NAME |
Pfizer Inc. |
| STREET |
235 East 42nd Street |
| CITY |
New York |
| STATE |
New York |
| COUNTRY |
United States |
| ZIP/POSTAL CODE |
10017 |
| PHONE |
212-733-1112 |
| FEE INFORMATION |
| NUMBER OF CLASSES |
1 |
| FEE PER CLASS |
325 |
| *TOTAL FEE DUE |
325 |
| *TOTAL FEE PAID |
325 |
| SIGNATURE INFORMATION |
| SIGNATURE |
/Seana Smith/ |
| SIGNATORY'S NAME |
Seana Smith |
| SIGNATORY'S POSITION |
Corporate Counsel - Trademarks |
| DATE SIGNED |
11/22/2013 |
| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
| Serial Number: 86126490 |
| Filing Date: 11/22/2013 |
To the Commissioner for Trademarks:
MARK: XELJANZ (stylized and/or with design, see
mark)
The literal element of the mark consists of XELJANZ.
The mark consists of word XELJANZ with starburst design.
The applicant, Pfizer Inc., a corporation of Delaware, having an address of
235 East 42nd Street
New York, New York 10017
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 044: health information services, namely, providing information related to the treatment of immunological and inflammatory diseases and
the treatment of pain; on-line information services, namely, providing information related to the treatment of immunological and inflammatory diseases and the treatment of pain
In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 11/30/2012, and first used in
commerce at least as early as 11/30/2012, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods and/or services, consisting of a(n) page from the xeljanz.com website.
Original PDF file:
SPE0-16822416014-114151042_._RA_Treatment___XELJANZ___tofacitinib_citrate_.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
The applicant claims ownership of U.S. Registration Number(s) 4099367.
The applicant's current Attorney Information:
Seana Smith and Tiffany Trunko, Richard A. Friedman, Heather A. McDonald, Katrina Edge, Matthew A. Pater, Michele A. Farber of Pfizer Inc.
235 East 42nd Street
New York, New York 10017
United States
The attorney docket/reference number is XELJANZ Logo/US.
| The applicant's current Correspondence Information: |
| Seana Smith |
| Pfizer Inc. |
| 235 East 42nd Street |
| New York, New York 10017 |
| 212-733-1112(phone) |
A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Declaration Signature
Signature: /Seana Smith/ Date: 11/22/2013
Signatory's Name: Seana Smith
Signatory's Position: Corporate Counsel - Trademarks
RAM Sale Number: 86126490
RAM Accounting Date: 11/22/2013
Serial Number: 86126490
Internet Transmission Date: Fri Nov 22 11:54:16 EST 2013
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201311221154160
74151-86126490-50089bcb4d47ae2a650c3a573
b2c38a459d376766407a3c7a8df76964c845e82d
5d-DA-10261-20131122114151042459
